Deciphering the Enigma: A Comprehensive Approach to Acute Chest Pain in Clinical Practice

Introduction

Acute chest pain (ACP) remains a diagnostic challenge in clinical practice due to its multifactorial etiology. The urgency associated with conditions like acute coronary syndrome (ACS) necessitates a comprehensive approach to ACP.

Initial Evaluation

The initial evaluation of ACP should involve a detailed history, physical examination, and electrocardiogram (ECG). The clinician should consider the patient's age, gender, risk factors, and the nature of the pain. Typical ACS pain is often described as heavy or squeezing, but atypical presentations are not uncommon.

Diagnostic Testing

High-sensitivity cardiac troponin (hs-cTn) is the cornerstone of ACS diagnosis. If the initial hs-cTn is negative, a repeat measurement should be done in 1-2 hours. Non-cardiac causes of raised hs-cTn, such as kidney disease, should also be considered. Additional investigations may include chest X-ray, echocardiogram, or coronary angiography, depending on the clinical suspicion.

Risk Stratification

Risk stratification using validated tools like the HEART score can guide management. Low-risk patients may be managed with outpatient testing, while high-risk patients require hospitalization and invasive evaluation. The role of newer risk stratification tools, such as the PROMISE and SCOT-HEART trials, are being explored.

Management

Management should be tailored to the underlying cause. ACS management includes antiplatelet therapy, statins, beta-blockers, and possibly revascularization. Non-cardiac causes of ACP, such as gastrointestinal or musculoskeletal conditions, require specific treatments.

Conclusion

ACP is a complex clinical entity requiring a comprehensive approach. Initial evaluation, diagnostic testing, risk stratification, and tailored management are crucial to improving patient outcomes. Further research is needed to refine risk stratification tools and to understand the role of novel biomarkers in ACP.